Side Effects of Pristiq (Desvenlafaxine)
Pristiq commonly causes nausea, dizziness, insomnia, constipation, sweating, sexual dysfunction, and headache, with nausea being the most frequent reason patients stop the medication. 1
Common Side Effects (Occurring in ≥5% of Patients)
The FDA-approved labeling identifies the following most frequent adverse reactions 1:
- Gastrointestinal: Nausea (most common), constipation, dry mouth, vomiting, diarrhea
- Neurological: Dizziness, headache, insomnia, somnolence
- Autonomic: Hyperhidrosis (excessive sweating) - occurs in 10-21% depending on dose
- Metabolic: Decreased appetite
- Psychiatric: Anxiety, abnormal dreams
Nausea and vomiting are the leading causes of treatment discontinuation in clinical trials 2. This is consistent across the SNRI class, though venlafaxine (the parent compound) shows even higher rates of nausea than other antidepressants 2.
Sexual Dysfunction
Sexual side effects are common and significantly underreported 2, 1. In clinical trials:
In men (occurring in ≥2%):
- Erectile dysfunction: 3-11% (dose-dependent)
- Delayed ejaculation: 1-7%
- Decreased libido: 4-6%
- Abnormal orgasm: 1-3%
- Ejaculation disorder/failure: 1-5%
In women (occurring in ≥2%):
- Anorgasmia: 1-3%
- Decreased libido (similar to men)
The FDA label specifically warns that sexual dysfunction may not be spontaneously reported by patients, requiring direct inquiry before and during treatment 1.
Serious Adverse Effects Requiring Monitoring
Cardiovascular Effects
Pristiq can increase blood pressure and heart rate 1. The evidence shows venlafaxine (and by extension desvenlafaxine) carries higher cardiovascular risk than SSRIs 2. Monitor blood pressure before starting treatment and regularly during therapy.
Bleeding Risk
Combining Pristiq with NSAIDs, aspirin, antiplatelet drugs, or anticoagulants increases bleeding risk 1. This is a class effect of serotonergic antidepressants 2.
Serotonin Syndrome
Life-threatening serotonin syndrome can occur, particularly when combined with other serotonergic medications (MAOIs, triptans, tramadol, fentanyl, other SSRIs/SNRIs, St. John's Wort) 1.
Symptoms include:
- Agitation, confusion, hallucinations
- Tachycardia, blood pressure changes
- Hyperthermia, sweating
- Tremor, muscle rigidity, myoclonus
- Nausea, vomiting, diarrhea
- Seizures, coma (severe cases)
Serotonin syndrome occurs in 14-16% of SSRI/SNRI overdoses 3.
Suicidality
Black box warning: Increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults (up to age 24) during initial treatment 1. While studies show no difference in suicidality between second-generation antidepressants, SSRIs/SNRIs as a class increase risk of nonfatal suicide attempts (OR 1.57-2.25) 2.
Discontinuation Syndrome
Abrupt cessation causes withdrawal symptoms 1. Symptoms can be severe and prolonged:
- Dizziness, electric shock sensations (paresthesias)
- Anxiety, irritability, agitation, aggression
- Insomnia, abnormal dreams
- Nausea, sweating
- Headache, tremor
- Confusion, mood changes
- Seizures (rare but serious)
Taper gradually - a 25 mg dose is available specifically for discontinuation 1.
Other Serious Effects
Hyponatremia: Can be severe and life-threatening, presenting with headache, confusion, weakness, falls, seizures, or coma 1.
Angle-closure glaucoma: Antidepressants including Pristiq can trigger acute angle-closure glaucoma. Monitor for eye pain or vision changes 1.
Seizures: Increased risk, particularly at higher doses 2, 1.
Activation of mania/hypomania: Screen for bipolar disorder before initiating treatment 1.
Interstitial lung disease/eosinophilic pneumonia: Rare but serious. Monitor for dyspnea, cough, or chest discomfort 1.
Dose-Related Patterns
Clinical trials demonstrate dose-dependent increases in adverse effects without additional efficacy above 50 mg/day 4, 5, 6. The 50 mg dose shows similar discontinuation rates to placebo (4.1% vs 3.8%), while the 100 mg dose shows doubled discontinuation rates (8.7%) 1.
Higher doses (200-400 mg) show significantly increased rates of:
- Hyperhidrosis (18-21% at 400 mg vs 4% at 50 mg)
- Sexual dysfunction (substantially higher across all parameters)
- Nausea and vomiting
- Dizziness and other CNS effects
Special Populations
Pregnancy: May increase risk of preterm delivery. Neonates exposed late in pregnancy may experience withdrawal symptoms or persistent pulmonary hypertension 3, 1.
Elderly patients: Higher risk of hyponatremia, falls (due to dizziness), and bleeding complications 2.
Hepatic/renal impairment: Dose adjustment required; maximum 100 mg/day in moderate-severe hepatic impairment, alternate-day dosing in severe renal impairment 7, 8.
Clinical Pearls
- Directly ask about sexual side effects - patients rarely volunteer this information 1
- Monitor blood pressure at baseline and during treatment 1
- Screen medication lists for serotonergic drugs and bleeding risk medications 1
- Never stop abruptly - taper to minimize discontinuation syndrome 1
- The 50 mg dose is optimal - higher doses increase side effects without improving efficacy 4, 5, 6